nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—HTR1D—meninx—sarcoma	0.119	0.205	CbGeAlD
Lisuride—HTR1B—dura mater—sarcoma	0.113	0.194	CbGeAlD
Lisuride—HTR1D—dura mater—sarcoma	0.109	0.188	CbGeAlD
Lisuride—HTR2A—pulmonary artery—sarcoma	0.0232	0.0399	CbGeAlD
Lisuride—HTR2A—hindlimb—sarcoma	0.014	0.0241	CbGeAlD
Lisuride—Pulmonary fibrosis—Etoposide—sarcoma	0.0138	0.0329	CcSEcCtD
Lisuride—Myoclonus—Vincristine—sarcoma	0.0124	0.0297	CcSEcCtD
Lisuride—HTR2A—appendage—sarcoma	0.012	0.0207	CbGeAlD
Lisuride—DRD5—hematopoietic system—sarcoma	0.012	0.0206	CbGeAlD
Lisuride—DRD4—testis—sarcoma	0.00996	0.0172	CbGeAlD
Lisuride—DRD5—lymphoid tissue—sarcoma	0.00843	0.0145	CbGeAlD
Lisuride—Pericardial effusion—Epirubicin—sarcoma	0.00829	0.0198	CcSEcCtD
Lisuride—Pericarditis—Epirubicin—sarcoma	0.00786	0.0187	CcSEcCtD
Lisuride—HTR2B—myometrium—sarcoma	0.00778	0.0134	CbGeAlD
Lisuride—Pericardial effusion—Doxorubicin—sarcoma	0.00767	0.0183	CcSEcCtD
Lisuride—Pericarditis—Doxorubicin—sarcoma	0.00727	0.0173	CcSEcCtD
Lisuride—HTR2A—endothelium—sarcoma	0.00726	0.0125	CbGeAlD
Lisuride—HTR1D—connective tissue—sarcoma	0.00691	0.0119	CbGeAlD
Lisuride—ADRB1—connective tissue—sarcoma	0.00671	0.0116	CbGeAlD
Lisuride—ADRA2C—myometrium—sarcoma	0.00612	0.0105	CbGeAlD
Lisuride—HTR1A—hematopoietic system—sarcoma	0.00598	0.0103	CbGeAlD
Lisuride—HTR2B—smooth muscle tissue—sarcoma	0.00588	0.0101	CbGeAlD
Lisuride—HTR2B—skin of body—sarcoma	0.0058	0.01	CbGeAlD
Lisuride—Dehydration—Thiotepa—sarcoma	0.0057	0.0136	CcSEcCtD
Lisuride—ADRA2C—seminal vesicle—sarcoma	0.00553	0.00952	CbGeAlD
Lisuride—ADRB1—cardiac atrium—sarcoma	0.0053	0.00912	CbGeAlD
Lisuride—Dehydration—Vincristine—sarcoma	0.00505	0.0121	CcSEcCtD
Lisuride—HTR2B—uterus—sarcoma	0.00504	0.00868	CbGeAlD
Lisuride—Dehydration—Mitoxantrone—sarcoma	0.00492	0.0117	CcSEcCtD
Lisuride—ADRA2A—myometrium—sarcoma	0.00488	0.00841	CbGeAlD
Lisuride—Weight increased—Thiotepa—sarcoma	0.00482	0.0115	CcSEcCtD
Lisuride—Pleural effusion—Epirubicin—sarcoma	0.00444	0.0106	CcSEcCtD
Lisuride—HTR2B—tendon—sarcoma	0.00442	0.00761	CbGeAlD
Lisuride—ADRA2A—seminal vesicle—sarcoma	0.00441	0.0076	CbGeAlD
Lisuride—Weight decreased—Vincristine—sarcoma	0.00425	0.0101	CcSEcCtD
Lisuride—Hallucination—Thiotepa—sarcoma	0.00422	0.0101	CcSEcCtD
Lisuride—ADRA2A—hematopoietic system—sarcoma	0.00419	0.00722	CbGeAlD
Lisuride—Weight increased—Mitoxantrone—sarcoma	0.00416	0.00993	CcSEcCtD
Lisuride—Weight decreased—Mitoxantrone—sarcoma	0.00414	0.00987	CcSEcCtD
Lisuride—Pleural effusion—Doxorubicin—sarcoma	0.00411	0.0098	CcSEcCtD
Lisuride—ADRA2A—connective tissue—sarcoma	0.00404	0.00695	CbGeAlD
Lisuride—Sweating—Vincristine—sarcoma	0.00402	0.00958	CcSEcCtD
Lisuride—HTR2A—embryo—sarcoma	0.00399	0.00688	CbGeAlD
Lisuride—ADRA2C—cardiac atrium—sarcoma	0.00399	0.00687	CbGeAlD
Lisuride—ADRA2C—uterus—sarcoma	0.00397	0.00683	CbGeAlD
Lisuride—Cardiac disorder—Thiotepa—sarcoma	0.00394	0.00939	CcSEcCtD
Lisuride—Sweating—Mitoxantrone—sarcoma	0.00391	0.00933	CcSEcCtD
Lisuride—Angiopathy—Thiotepa—sarcoma	0.00385	0.00917	CcSEcCtD
Lisuride—Immune system disorder—Thiotepa—sarcoma	0.00383	0.00913	CcSEcCtD
Lisuride—Mediastinal disorder—Thiotepa—sarcoma	0.00382	0.00911	CcSEcCtD
Lisuride—Hallucination—Vincristine—sarcoma	0.00374	0.00892	CcSEcCtD
Lisuride—Mental disorder—Thiotepa—sarcoma	0.00371	0.00886	CcSEcCtD
Lisuride—Malnutrition—Thiotepa—sarcoma	0.00369	0.0088	CcSEcCtD
Lisuride—HTR2A—hematopoietic system—sarcoma	0.00357	0.00614	CbGeAlD
Lisuride—Cardiac disorder—Vincristine—sarcoma	0.00349	0.00832	CcSEcCtD
Lisuride—ADRA2C—tendon—sarcoma	0.00348	0.00599	CbGeAlD
Lisuride—HTR2A—connective tissue—sarcoma	0.00343	0.00591	CbGeAlD
Lisuride—Angiopathy—Vincristine—sarcoma	0.00341	0.00814	CcSEcCtD
Lisuride—Mediastinal disorder—Vincristine—sarcoma	0.00339	0.00808	CcSEcCtD
Lisuride—CYP3A4—hematopoietic system—sarcoma	0.0033	0.00568	CbGeAlD
Lisuride—Mental disorder—Vincristine—sarcoma	0.00329	0.00786	CcSEcCtD
Lisuride—CYP2D6—hematopoietic system—sarcoma	0.00325	0.00559	CbGeAlD
Lisuride—Cough—Thiotepa—sarcoma	0.00322	0.00768	CcSEcCtD
Lisuride—ADRA2A—cardiac atrium—sarcoma	0.00318	0.00548	CbGeAlD
Lisuride—ADRA2A—uterus—sarcoma	0.00317	0.00545	CbGeAlD
Lisuride—HTR2A—smooth muscle tissue—sarcoma	0.00314	0.00541	CbGeAlD
Lisuride—Anxiety—Thiotepa—sarcoma	0.00313	0.00747	CcSEcCtD
Lisuride—Confusional state—Thiotepa—sarcoma	0.00304	0.00724	CcSEcCtD
Lisuride—Infection—Thiotepa—sarcoma	0.00299	0.00714	CcSEcCtD
Lisuride—Infection—Dactinomycin—sarcoma	0.00297	0.00708	CcSEcCtD
Lisuride—DRD2—testis—sarcoma	0.00296	0.0051	CbGeAlD
Lisuride—Nervous system disorder—Thiotepa—sarcoma	0.00295	0.00705	CcSEcCtD
Lisuride—Vertigo—Vincristine—sarcoma	0.00294	0.00701	CcSEcCtD
Lisuride—Tachycardia—Thiotepa—sarcoma	0.00294	0.00701	CcSEcCtD
Lisuride—ADRA2C—testis—sarcoma	0.00288	0.00496	CbGeAlD
Lisuride—Anorexia—Thiotepa—sarcoma	0.00287	0.00685	CcSEcCtD
Lisuride—Anorexia—Dactinomycin—sarcoma	0.00285	0.0068	CcSEcCtD
Lisuride—Cardiac disorder—Etoposide—sarcoma	0.00283	0.00674	CcSEcCtD
Lisuride—Cough—Mitoxantrone—sarcoma	0.00278	0.00663	CcSEcCtD
Lisuride—ADRA2A—tendon—sarcoma	0.00277	0.00478	CbGeAlD
Lisuride—Angiopathy—Etoposide—sarcoma	0.00276	0.00659	CcSEcCtD
Lisuride—Immune system disorder—Etoposide—sarcoma	0.00275	0.00656	CcSEcCtD
Lisuride—Mediastinal disorder—Etoposide—sarcoma	0.00275	0.00655	CcSEcCtD
Lisuride—ADRA2C—liver—sarcoma	0.00272	0.00469	CbGeAlD
Lisuride—Anxiety—Mitoxantrone—sarcoma	0.0027	0.00645	CcSEcCtD
Lisuride—Somnolence—Thiotepa—sarcoma	0.00268	0.00639	CcSEcCtD
Lisuride—Infection—Vincristine—sarcoma	0.00265	0.00633	CcSEcCtD
Lisuride—HTR2B—lymph node—sarcoma	0.00265	0.00457	CbGeAlD
Lisuride—Confusional state—Mitoxantrone—sarcoma	0.00262	0.00626	CcSEcCtD
Lisuride—Nervous system disorder—Vincristine—sarcoma	0.00262	0.00625	CcSEcCtD
Lisuride—Decreased appetite—Thiotepa—sarcoma	0.00262	0.00625	CcSEcCtD
Lisuride—Gastrointestinal disorder—Thiotepa—sarcoma	0.0026	0.0062	CcSEcCtD
Lisuride—Decreased appetite—Dactinomycin—sarcoma	0.0026	0.0062	CcSEcCtD
Lisuride—Fatigue—Thiotepa—sarcoma	0.0026	0.00619	CcSEcCtD
Lisuride—Infection—Mitoxantrone—sarcoma	0.00258	0.00616	CcSEcCtD
Lisuride—Hyperhidrosis—Vincristine—sarcoma	0.00258	0.00616	CcSEcCtD
Lisuride—Fatigue—Dactinomycin—sarcoma	0.00258	0.00615	CcSEcCtD
Lisuride—Constipation—Thiotepa—sarcoma	0.00258	0.00614	CcSEcCtD
Lisuride—Anorexia—Vincristine—sarcoma	0.00255	0.00607	CcSEcCtD
Lisuride—Tachycardia—Mitoxantrone—sarcoma	0.00254	0.00606	CcSEcCtD
Lisuride—Hyperhidrosis—Mitoxantrone—sarcoma	0.00251	0.006	CcSEcCtD
Lisuride—Feeling abnormal—Thiotepa—sarcoma	0.00248	0.00592	CcSEcCtD
Lisuride—Anorexia—Mitoxantrone—sarcoma	0.00248	0.00591	CcSEcCtD
Lisuride—Feeling abnormal—Dactinomycin—sarcoma	0.00246	0.00588	CcSEcCtD
Lisuride—Insomnia—Vincristine—sarcoma	0.00242	0.00576	CcSEcCtD
Lisuride—Vertigo—Etoposide—sarcoma	0.00238	0.00568	CcSEcCtD
Lisuride—HTR2A—tendon—sarcoma	0.00236	0.00406	CbGeAlD
Lisuride—Decreased appetite—Vincristine—sarcoma	0.00232	0.00554	CcSEcCtD
Lisuride—Dyspnoea—Mitoxantrone—sarcoma	0.00232	0.00553	CcSEcCtD
Lisuride—Cough—Etoposide—sarcoma	0.00231	0.00552	CcSEcCtD
Lisuride—Somnolence—Mitoxantrone—sarcoma	0.00231	0.00552	CcSEcCtD
Lisuride—Gastrointestinal disorder—Vincristine—sarcoma	0.00231	0.0055	CcSEcCtD
Lisuride—Fatigue—Vincristine—sarcoma	0.0023	0.00549	CcSEcCtD
Lisuride—ADRA2A—testis—sarcoma	0.0023	0.00396	CbGeAlD
Lisuride—Dehydration—Epirubicin—sarcoma	0.0023	0.00547	CcSEcCtD
Lisuride—Constipation—Vincristine—sarcoma	0.00228	0.00545	CcSEcCtD
Lisuride—Decreased appetite—Mitoxantrone—sarcoma	0.00226	0.00539	CcSEcCtD
Lisuride—Orthostatic hypotension—Epirubicin—sarcoma	0.00225	0.00538	CcSEcCtD
Lisuride—Fatigue—Mitoxantrone—sarcoma	0.00224	0.00535	CcSEcCtD
Lisuride—Constipation—Mitoxantrone—sarcoma	0.00222	0.00531	CcSEcCtD
Lisuride—Confusional state—Etoposide—sarcoma	0.00218	0.0052	CcSEcCtD
Lisuride—Asthenia—Thiotepa—sarcoma	0.00216	0.00515	CcSEcCtD
Lisuride—Infection—Etoposide—sarcoma	0.00215	0.00513	CcSEcCtD
Lisuride—Asthenia—Dactinomycin—sarcoma	0.00215	0.00512	CcSEcCtD
Lisuride—Feeling abnormal—Mitoxantrone—sarcoma	0.00214	0.00511	CcSEcCtD
Lisuride—Dehydration—Doxorubicin—sarcoma	0.00212	0.00506	CcSEcCtD
Lisuride—Tachycardia—Etoposide—sarcoma	0.00211	0.00504	CcSEcCtD
Lisuride—Hyperhidrosis—Etoposide—sarcoma	0.00209	0.00499	CcSEcCtD
Lisuride—ADRA2C—lymph node—sarcoma	0.00209	0.00359	CbGeAlD
Lisuride—Orthostatic hypotension—Doxorubicin—sarcoma	0.00209	0.00497	CcSEcCtD
Lisuride—Anorexia—Etoposide—sarcoma	0.00206	0.00492	CcSEcCtD
Lisuride—Dizziness—Thiotepa—sarcoma	0.00199	0.00475	CcSEcCtD
Lisuride—HTR2A—testis—sarcoma	0.00195	0.00336	CbGeAlD
Lisuride—Weight increased—Epirubicin—sarcoma	0.00194	0.00463	CcSEcCtD
Lisuride—Weight decreased—Epirubicin—sarcoma	0.00193	0.0046	CcSEcCtD
Lisuride—Dyspnoea—Etoposide—sarcoma	0.00193	0.0046	CcSEcCtD
Lisuride—Somnolence—Etoposide—sarcoma	0.00192	0.00459	CcSEcCtD
Lisuride—Asthenia—Vincristine—sarcoma	0.00192	0.00457	CcSEcCtD
Lisuride—Vomiting—Thiotepa—sarcoma	0.00192	0.00457	CcSEcCtD
Lisuride—Vomiting—Dactinomycin—sarcoma	0.0019	0.00453	CcSEcCtD
Lisuride—Headache—Thiotepa—sarcoma	0.00189	0.0045	CcSEcCtD
Lisuride—Decreased appetite—Etoposide—sarcoma	0.00188	0.00449	CcSEcCtD
Lisuride—Gastrointestinal disorder—Etoposide—sarcoma	0.00187	0.00446	CcSEcCtD
Lisuride—Asthenia—Mitoxantrone—sarcoma	0.00187	0.00445	CcSEcCtD
Lisuride—Fatigue—Etoposide—sarcoma	0.00187	0.00445	CcSEcCtD
Lisuride—Constipation—Etoposide—sarcoma	0.00185	0.00441	CcSEcCtD
Lisuride—HTR2A—liver—sarcoma	0.00185	0.00318	CbGeAlD
Lisuride—Sweating—Epirubicin—sarcoma	0.00182	0.00435	CcSEcCtD
Lisuride—Weight increased—Doxorubicin—sarcoma	0.0018	0.00428	CcSEcCtD
Lisuride—Weight decreased—Doxorubicin—sarcoma	0.00179	0.00426	CcSEcCtD
Lisuride—Feeling abnormal—Etoposide—sarcoma	0.00178	0.00425	CcSEcCtD
Lisuride—CYP2D6—testis—sarcoma	0.00178	0.00306	CbGeAlD
Lisuride—Dizziness—Vincristine—sarcoma	0.00177	0.00421	CcSEcCtD
Lisuride—CYP3A4—liver—sarcoma	0.00171	0.00294	CbGeAlD
Lisuride—Vomiting—Vincristine—sarcoma	0.0017	0.00405	CcSEcCtD
Lisuride—Sweating—Doxorubicin—sarcoma	0.00169	0.00402	CcSEcCtD
Lisuride—CYP2D6—liver—sarcoma	0.00168	0.0029	CbGeAlD
Lisuride—Oedema peripheral—Epirubicin—sarcoma	0.00168	0.00401	CcSEcCtD
Lisuride—Headache—Vincristine—sarcoma	0.00167	0.00399	CcSEcCtD
Lisuride—ADRA2A—lymph node—sarcoma	0.00167	0.00287	CbGeAlD
Lisuride—Vomiting—Mitoxantrone—sarcoma	0.00165	0.00394	CcSEcCtD
Lisuride—Headache—Mitoxantrone—sarcoma	0.00163	0.00389	CcSEcCtD
Lisuride—Cardiac disorder—Epirubicin—sarcoma	0.00158	0.00378	CcSEcCtD
Lisuride—Oedema peripheral—Doxorubicin—sarcoma	0.00156	0.00371	CcSEcCtD
Lisuride—Asthenia—Etoposide—sarcoma	0.00155	0.0037	CcSEcCtD
Lisuride—Angiopathy—Epirubicin—sarcoma	0.00155	0.00369	CcSEcCtD
Lisuride—Immune system disorder—Epirubicin—sarcoma	0.00154	0.00368	CcSEcCtD
Lisuride—Mediastinal disorder—Epirubicin—sarcoma	0.00154	0.00367	CcSEcCtD
Lisuride—Mental disorder—Epirubicin—sarcoma	0.0015	0.00357	CcSEcCtD
Lisuride—Malnutrition—Epirubicin—sarcoma	0.00149	0.00354	CcSEcCtD
Lisuride—Cardiac disorder—Doxorubicin—sarcoma	0.00147	0.0035	CcSEcCtD
Lisuride—Angiopathy—Doxorubicin—sarcoma	0.00143	0.00342	CcSEcCtD
Lisuride—Dizziness—Etoposide—sarcoma	0.00143	0.00341	CcSEcCtD
Lisuride—Immune system disorder—Doxorubicin—sarcoma	0.00143	0.0034	CcSEcCtD
Lisuride—Mediastinal disorder—Doxorubicin—sarcoma	0.00142	0.0034	CcSEcCtD
Lisuride—Mental disorder—Doxorubicin—sarcoma	0.00138	0.0033	CcSEcCtD
Lisuride—Vomiting—Etoposide—sarcoma	0.00138	0.00328	CcSEcCtD
Lisuride—Malnutrition—Doxorubicin—sarcoma	0.00138	0.00328	CcSEcCtD
Lisuride—Headache—Etoposide—sarcoma	0.00136	0.00323	CcSEcCtD
Lisuride—Vertigo—Epirubicin—sarcoma	0.00134	0.00318	CcSEcCtD
Lisuride—Syncope—Epirubicin—sarcoma	0.00133	0.00318	CcSEcCtD
Lisuride—Palpitations—Epirubicin—sarcoma	0.00131	0.00313	CcSEcCtD
Lisuride—Cough—Epirubicin—sarcoma	0.0013	0.00309	CcSEcCtD
Lisuride—Anxiety—Epirubicin—sarcoma	0.00126	0.00301	CcSEcCtD
Lisuride—Dry mouth—Epirubicin—sarcoma	0.00124	0.00295	CcSEcCtD
Lisuride—Vertigo—Doxorubicin—sarcoma	0.00124	0.00295	CcSEcCtD
Lisuride—Syncope—Doxorubicin—sarcoma	0.00123	0.00294	CcSEcCtD
Lisuride—Confusional state—Epirubicin—sarcoma	0.00122	0.00292	CcSEcCtD
Lisuride—Palpitations—Doxorubicin—sarcoma	0.00122	0.0029	CcSEcCtD
Lisuride—Infection—Epirubicin—sarcoma	0.00121	0.00287	CcSEcCtD
Lisuride—Cough—Doxorubicin—sarcoma	0.0012	0.00286	CcSEcCtD
Lisuride—Nervous system disorder—Epirubicin—sarcoma	0.00119	0.00284	CcSEcCtD
Lisuride—Tachycardia—Epirubicin—sarcoma	0.00118	0.00282	CcSEcCtD
Lisuride—Hyperhidrosis—Epirubicin—sarcoma	0.00117	0.0028	CcSEcCtD
Lisuride—Anxiety—Doxorubicin—sarcoma	0.00117	0.00278	CcSEcCtD
Lisuride—Anorexia—Epirubicin—sarcoma	0.00116	0.00276	CcSEcCtD
Lisuride—Dry mouth—Doxorubicin—sarcoma	0.00115	0.00273	CcSEcCtD
Lisuride—Confusional state—Doxorubicin—sarcoma	0.00113	0.0027	CcSEcCtD
Lisuride—Infection—Doxorubicin—sarcoma	0.00112	0.00266	CcSEcCtD
Lisuride—Nervous system disorder—Doxorubicin—sarcoma	0.0011	0.00262	CcSEcCtD
Lisuride—Insomnia—Epirubicin—sarcoma	0.0011	0.00262	CcSEcCtD
Lisuride—Tachycardia—Doxorubicin—sarcoma	0.0011	0.00261	CcSEcCtD
Lisuride—Hyperhidrosis—Doxorubicin—sarcoma	0.00109	0.00259	CcSEcCtD
Lisuride—Dyspnoea—Epirubicin—sarcoma	0.00108	0.00258	CcSEcCtD
Lisuride—Somnolence—Epirubicin—sarcoma	0.00108	0.00257	CcSEcCtD
Lisuride—Anorexia—Doxorubicin—sarcoma	0.00107	0.00255	CcSEcCtD
Lisuride—Decreased appetite—Epirubicin—sarcoma	0.00105	0.00251	CcSEcCtD
Lisuride—Gastrointestinal disorder—Epirubicin—sarcoma	0.00105	0.0025	CcSEcCtD
Lisuride—Fatigue—Epirubicin—sarcoma	0.00105	0.00249	CcSEcCtD
Lisuride—Constipation—Epirubicin—sarcoma	0.00104	0.00247	CcSEcCtD
Lisuride—Insomnia—Doxorubicin—sarcoma	0.00102	0.00242	CcSEcCtD
Lisuride—Dyspnoea—Doxorubicin—sarcoma	0.001	0.00239	CcSEcCtD
Lisuride—Feeling abnormal—Epirubicin—sarcoma	0.001	0.00238	CcSEcCtD
Lisuride—Somnolence—Doxorubicin—sarcoma	0.000998	0.00238	CcSEcCtD
Lisuride—Decreased appetite—Doxorubicin—sarcoma	0.000976	0.00233	CcSEcCtD
Lisuride—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000969	0.00231	CcSEcCtD
Lisuride—Fatigue—Doxorubicin—sarcoma	0.000968	0.00231	CcSEcCtD
Lisuride—Constipation—Doxorubicin—sarcoma	0.00096	0.00229	CcSEcCtD
Lisuride—Feeling abnormal—Doxorubicin—sarcoma	0.000925	0.00221	CcSEcCtD
Lisuride—Asthenia—Epirubicin—sarcoma	0.00087	0.00208	CcSEcCtD
Lisuride—Asthenia—Doxorubicin—sarcoma	0.000805	0.00192	CcSEcCtD
Lisuride—Dizziness—Epirubicin—sarcoma	0.000802	0.00191	CcSEcCtD
Lisuride—Vomiting—Epirubicin—sarcoma	0.000771	0.00184	CcSEcCtD
Lisuride—Headache—Epirubicin—sarcoma	0.00076	0.00181	CcSEcCtD
Lisuride—Dizziness—Doxorubicin—sarcoma	0.000742	0.00177	CcSEcCtD
Lisuride—Vomiting—Doxorubicin—sarcoma	0.000714	0.0017	CcSEcCtD
Lisuride—Headache—Doxorubicin—sarcoma	0.000703	0.00168	CcSEcCtD
